1800 202 8726
Drug deep dive: Sunitinib

Sunitinib: — 4 Weeks On, 2 Weeks Off — and the 2/1 Option

Sunitinib is taken on a planned cycle, not every day without a break. Understanding when you take it and when you stop is the first thing most people want to know after collecting their prescription.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026

  • One cycle is 42 days — 28 days of tablets, then 14 days off. That six-week block repeats for as long as the treatment is working.
  • The break is part of the treatment — The 14 off-days are not a pause — they give your body time to recover before the next on-phase begins.
  • A shorter cycle exists — The 2/1 schedule — 14 days on, 7 days off — is a recognised NCCN alternative, most often considered when side effects are hard to manage.
  • Your oncologist decides — Both schedules use the same tablet dose. The choice depends on how you tolerate the drug and how it is working for you.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Sunitinib is taken once daily for 4 weeks, then stopped for 2 weeks — those 42 days are one cycle. A shorter option, 2 weeks on and 1 week off in a 21-day cycle, is also recognised by NCCN. Both use the same dose. Your oncologist chooses the schedule based on how you tolerate the drug.

How does the 4-weeks-on, 2-weeks-off schedule work?

You take one sunitinib tablet every day for 28 days. Then you take no tablets for 14 days. Those 42 days together are one cycle.

The two-week break is built into the treatment plan. It is not a sign that anything has gone wrong — the off-days give your body time to recover from the drug's effects before the next cycle begins.

Most people repeat this six-week cycle for as long as treatment is working and side effects stay manageable. Your oncologist reviews your blood results and symptoms before each new cycle starts.

What should you track through each cycle?

  • Days 1–28: Take your tablet at the same time each day. Food is optional — pick whichever approach suits you and stay consistent.
  • Days 29–42: No tablets, but keep reporting any new or worsening symptoms to your team — the break does not pause your monitoring.
  • Attend blood test appointments during your off weeks. These results help decide whether your next cycle starts on schedule.
  • Note which days your fatigue or side effects feel worst. Your team will ask this if a schedule change comes up.
  • If you miss a dose, do not take two the next day. Let your team know at your next check-in.
  • Before starting any new medicine, supplement or herbal preparation, tell your oncology team or pharmacist first.

What is the 2-weeks-on, 1-week-off schedule?

The 2/1 schedule means 14 days of tablets followed by 7 days off, repeated in a three-week cycle. The tablet dose stays the same as on the standard schedule.

It was developed because sunitinib's side effects tend to build up towards the end of the four-week on-phase. A shorter on-phase gives your body more frequent recovery time before those effects become severe.

NCCN includes the 2/1 schedule as a recognised alternative. Studies have compared it directly with the standard schedule, and your oncologist will weigh that evidence against your individual situation.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

When might your oncologist suggest switching to the 2/1 schedule?

A switch is most often considered when side effects in the final weeks of the on-phase are consistently difficult — severe fatigue, significant hand-foot syndrome, or nausea that has not settled before the next cycle starts.

The decision is individual. Your oncologist looks at your response to treatment, which side effects are most disruptive to daily life, and your overall fitness.

Switching schedules is not a sign that the treatment is failing. It is an adjustment to help you stay on therapy for as long as it is working.

What do these terms mean?

Cycle
One complete on-off sequence. On the 4/2 schedule, a cycle is 42 days. On the 2/1 schedule, it is 21 days.
On-phase
The days when you take the tablet. Sunitinib is active in your body throughout this period.
Off-phase
The days with no tablet. Side effects often ease during this time, though some effects carry into the first days of the break before fading.
Dose reduction
If side effects are significant, your oncologist may lower the daily tablet dose rather than change the schedule — or combine both adjustments.
Hand-foot syndrome
Redness, tenderness or peeling on the palms and soles. A common sunitinib effect that typically builds through the on-phase and eases during the break.

Did you know?

Sunitinib and its main active breakdown product have a long combined presence in the body — the drug keeps working for days after you take your last tablet of the cycle.

This is why some side effects carry into the first days of your break before they ease. The off-phase is doing something, even when it does not feel that way immediately.

Source: NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer

Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics

Drug Deep Dive: Sunitinib (Sutent)

All Kidney, Ovarian & Sarcoma Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Why 4 weeks on and 2 weeks off — why not take it every day?

Sunitinib affects normal tissue alongside cancer cells, and continuous daily use would not give your body the recovery time it needs. The off-phase is when many side effects settle and tolerance rebuilds before the next on-phase. The 4/2 schedule was established through clinical trials for this reason. The 2/1 schedule shortens both phases and was designed to spread that recovery more evenly across the month.

Can I take a longer break if I feel very tired?

Extending your break without guidance from your team is not recommended. The length of the off-phase is planned for clinical reasons, and taking extra time off on your own can affect how treatment works overall. If fatigue is severe enough that you feel you need more time, that is important information — tell your oncologist. There are planned ways to adjust the schedule or dose rather than improvising a longer break yourself.

Is the 2/1 schedule as effective as the standard schedule?

Studies comparing the two schedules have been published, and NCCN recognises both as options. We do not yet have enough long-term data to say definitively whether one is better than the other for all patients, which is why the decision is made individually. Your oncologist will weigh the available evidence against your specific situation rather than applying a single answer.

What happens if I accidentally take a tablet on an off day?

One extra tablet on an off day is unlikely to cause a serious problem, but tell your oncology team at your next contact. Do not try to compensate by skipping doses later. If you notice any unusual symptoms after the extra tablet, contact your team the same day. Keeping a simple calendar with on and off days marked is one of the most reliable ways to prevent this kind of error.

How many cycles of sunitinib will I need?

There is no fixed number decided in advance. Treatment continues for as long as it is working — meaning your cancer is responding or staying stable — and side effects remain manageable. Your oncologist assesses this at regular intervals using scans and blood tests. Some people are on sunitinib for many months; others need a change of treatment sooner. That decision is reviewed cycle by cycle based on your results.

Does the schedule change if the cancer stops responding?

If sunitinib stops controlling the cancer, changing the schedule does not change that outcome. Your oncologist will discuss moving to a different treatment rather than adjusting the timing. The schedule is modified for tolerability, not for response. If you are concerned that your cancer may not be responding, the right question to bring to your next appointment is about your scan results and whether a change of treatment is being planned.

Call now Book free consultation